Introduction
excitation of the plasmalemma followed by the typical long lasting cardiac action potential. Calcium entering the The mammalian organism responds to chronic pressure myocytes during the plateau phase of the action potential 21 and volume overload of the heart with a plethora of mainly via voltage sensitive L-type Ca channels serves 21 adaptive changes that consist of resetting of the neuroas a trigger for further release of Ca from the major 21 humoral homeostasis on a more general level and of intracellular store, the SR. The free cytosolic Ca con- potential duration and rhythm disturbances considered initiated mainly by reuptake of Ca into the SR. Release 21 responsible for sudden cardiac death as well as depression and uptake of Ca occur in different structural entities of 21 in contractile function of individual myocytes. Since the SR. The special ryanodine-sensitive Ca release 21 calcium ions (Ca ) play a pivotal role in cardiac excitachannels are localized within close vicinity of the sar- 21 tion-contraction coupling, contractile dysfunction has been colemma, whereas the energy-consuming Ca -ATPase 21 21 interpreted as a defect in Ca -handling proteins of the for pumping Ca into the lumen is localized in the sarcoplasmic reticulum (SR) at the subcellular level.
longitudinal part of the SR. For maintenance of cellular 21 21 This survey begins with a brief outline of cardiac Ca homeostasis Ca influx must be compensated by 21 1 21 excitation-contraction coupling and the functional role of Ca removal from the cell via the Na -Ca exchanger 21 the SR Ca -ATPase and its regulatory protein phos- [8] . In addition, mitochondria have a large capacity for 21 pholamban. It continues with a summary of a frequently Ca uptake and release, however their contribution to the 21 21 cited paper on the modulatory changes in these two Ca [Ca ] transient during an individual contractile cycle is i homeostasis regulating proteins in human heart failure [1] less clear [9, 10] . and it will then discuss the confirmatory and controversial Any one of these subprocesses is a potential target of issues published since that seminal work appeared. The pathological changes in heart failure. Findings in muscle review will conclude with recently defined deficiencies at strips or single myocytes isolated from failing human other subcellular sites. In its course, the reader is frequenthearts include: prolongation of action potential duration ly referred to the excellent reviews of our current knowl-21 [4, 11, 12] , reduced amplitude of the intracellular [Ca ] i edge on the topic, which were compiled in the 1998 transients [13] [14] [15] , impaired force development particufocused issue of this journal [2] [3] [4] [5] [6] [7] .
larly at high frequencies of stimulation [11, 16] , and slowed relaxation [15, 17] . The conspicuous relaxation abnor-2. Cardiac excitation-contraction coupling malities in heart failure have been related to impairment of cellular calcium handling proteins [18] involving quantitaContraction of heart muscle is initiated by electrical tive and / or functional changes. This interpretation has led to a great amount of work devoted to the study of the 21 Three Ca -ATPase genes encode for the large proteins review, see Ref. [30] ). The inhibitory function of un- 21 21 that pump Ca into SR or endoplasmic reticulum for later phosphorylated phospholamban on SR Ca -ATPase can release [20] . The two isoforms of SERCA1 are expressed also be demonstrated in transgenic mice in which ablation in adult (SERCA1a) and neonatal (SERCA1b) fast twitchof the phospholamban gene is accompanied by an increase 21 ing skeletal muscle. The two isoforms of SERCA2 are in the SR Ca -ATPase affinity for calcium with enhanced found in slowly contracting muscles such as cardiac rates of contraction and relaxation as well as increased muscle (SERCA2a) and smooth muscle, and slow twitch pump rate [28, [31] [32] [33] , whereas overexpression of phos- 21 skeletal muscle (SERCA2b). Finally, SERCA3 existing in pholamban gene results in depressed SR Ca -ATPase a single isoform only is the subtype expressed in other affinity for calcium and decreased myocardial performance types of muscle and nonmuscle cells. The functional [34] . significance of the cardiac SERCA2 has been demonstrated While contractile proteins demonstrate an isoform shift in transgenic mice where overexpression of the gene in the development of heart failure [35] [36] [37] (for review, product enhances cardiac performance [21] [22] [23] . Interestsee Ref. [38] ), this has not been observed for SERCA2a or ingly, myocardial contractile function is also enhanced phospholamban [39] . when the fast twitch skeletal muscle isoform SERCA1a is selectively overexpressed in murine hearts, and this is associated with faster shortening and relaxation rates in isolated myocytes indicating that the isoform SERCA1a 3. Summary of a frequently cited paper on changes can substitute for the endogenous SERCA2a [24] .
in SR protein expression in end-stage heart failure [1]
21
The activity of the SR Ca pump is regulated by the small, 52-amino-acid protein phospholamban of which no Animal models of hypertrophy and failure reveal that subtypes are known (for review, see Ref. [19] ). In its basal mRNA of both SERCA2 and phospholamban are reduced unphosphorylated state, phospholamban inhibits the SR (Table 1 ; for review, see Ref. [39] ) and evidence for 21 Ca -ATPase by decreasing the affinity of the calcium similar alterations in end-stage human heart failure had 21 pump for Ca [25] [26] [27] , whereas in its phosphorylated been published by several groups before the study of Linck 21 state, it enhances the activity of SR Ca -ATPase [25] via et al. [1] (see Table 2 ). The general notion was that an increase in affinity of the pump for calcium without reduced mRNA levels implied reduced protein levels as change in maximum velocity of the enzyme [28, 29] .
well, and for SERCA2, this expectation had in fact been 21 Phosphorylation of myocardial phospholamban is catalysed confirmed [40] . On the other hand, impaired Ca uptake by several enzymes including calcium / calmodulin-depeninto the SR, i.e. impaired function, does not necessarily dent protein kinase and cAMP-dependent protein kinase A, indicate decreased protein levels of SERCA2 and / or with distinct sites of phosphorylation by either kinase (for phospholamban because the function of these proteins is 
Hasenfuss et al. 1999 [69] a DCM, dilated cardiomyopathy; ICM, ischemic cardiomyopathy; PPH, primary pulmonary hypertension. b n. d., not determined; ↓, decreased; →, no change.
regulated by the extent of phospholamban phosphorylation veloped in order to study also discrete changes. Frequently (see above) which can be downregulated by different and employed models attempt to simulate ischemia-induced, independent adaptations as for instance changes in the tachycardia-induced, and pressure-overload-induced heart b-adrenoceptor signaling cascade (for review, see Ref.
failure (for review, see Ref. [42] ). In these different animal [41] ). Based on these considerations, experiments were models of heart failure, expression of myocardial mRNA designed in which mRNA and protein contents were (and sometimes also of protein levels) for SERCA2 and determined in parallel in the same tissue samples and the phospholamban have been studied, but far less information results were analysed separately for ischemic caris available about the expression of phospholamban than 21 diomyopathy and idiopathic dilated cardiomyopathy. about the respective expression of SR Ca -ATPase Quantification of mRNA by hybridization of total RNA (Table 1) . Nevertheless, the results from these studies are 32 with P-labeled cDNAs for rat SERCA2 and human controversial and appear to be related to the particular phospholamban revealed that mRNA for SERCA2 was model of heart failure used. reduced by 50% and for phospholamban by 30% in failing For instance, in the rat model of chronic myocardial as compared with nonfailing control hearts, whereas the infarction studied several weeks after occlusion of the left concentrations for these two proteins as measured with coronary artery, myocardial mRNA and protein levels of 21 specific antibodies were not different. The authors sugthe SR Ca -ATPase are reported to be decreased [43, 44] gested that the apparent discrepancy between constant or unchanged [45, 46] , and no concomitant change in 21 protein levels and yet reduced SR Ca uptake function mRNA or protein content of phospholamban has been which is assumed as causal for impaired relaxation in heart detected [45] . This experimental model is considered to failure could be due to functional modification, e.g., altered represent ischemic cardiomyopathy. phosphorylation, of SR proteins. -Besides its specific Chronic, high-frequency pacing of rabbit, pig or dog topic, the work by Linck et al. [1] carries the more general hearts causes tachycardia-induced heart failure that appar- 21 message of a big caveat that extrapolation from cardiac ently does not affect the SR Ca -ATPase mRNA levels as mRNA levels to protein expression may be misleading.
reported in earlier studies [47] . However, more recent 21 results suggest a significant decrease in SR Ca -ATPase mRNA levels [48] [49] [50] , and, when investigated, protein 4. SR calcium pump and phospholamban in the level is also significantly decreased [48, 51] . For phosfailing animal heart pholamban, mRNA is found to be unchanged [47, 48] , whereas protein level is decreased [51] . It must be pointed While biochemical studies in human failing myocardium out, however, that here, mRNA and protein levels have are limited to the end-stages of the disease, various animal been investigated neither in the same probes nor in the models of hypertrophy and heart failure have been desame study.
Pressure-overload-induced heart failure develops after show that discriminating end-stage failing myocardium on aortic banding. In this model mRNA and protein levels for the basis of diastolic function yielded two distinct sub- 21 1 SR Ca -ATPase are consistently depressed in rat and groups, i.e., one with increased protein levels of Na - 21 guinea pig models [52] [53] [54] [55] [56] [57] [58] [59] . Interestingly, in most studies Ca exchanger but unchanged SERCA2 and another one this change is accompanied by concomitant decrease in with decreased protein level of SERCA2 but unchanged 1 21 mRNA for phospholamban [53, 57] and phospholamban Na -Ca exchanger [69] . In addition, the relative phos- 21 protein level [52, 58] with one controversial report of pholamban / SR Ca -ATPase ratio is critical in the regulaunchanged mRNA levels [56] .
tion of myocardial contractility and alterations of this ratio may contribute to the functional deterioration observed during heart failure [76, 77] All studies investigating mRNA for SR Ca -ATPase modulin-dependent protein kinase), any change leading to have yielded strikingly consistent results of lower mRNA altered protein kinase activation will also indirectly affect 21 levels in failing than in nonfailing myocardium irrespective regulation of the SR Ca pump. As pointed out in the of the underlying pathogenesis, i.e., ischemic carIntroduction, heart failure may be compensated by sympadiomyopathy or idiopathic dilated cardiomyopathy thetic activation that leads to elevation of norepinephrine [1, 40, [60] [61] [62] [63] [64] [65] . The same holds true for mRNA levels of plasma concentrations causing further counter regulation at phospholamban which are also depressed in failing as the receptor level. Thus in heart failure, the b-adrenoceptor compared with nonfailing tissue [1, [62] [63] [64] [65] [66] . Because of the signaling cascade, for instance, is functionally inactivated early assumption that protein expression always parallels because selective downregulation of b -adrenoceptors [78] 1 mRNA expression, many authors have omitted simultaand upregulation of b-adrenoceptor kinase leads to uncouneous determinations of mRNA and protein levels in the pling of the receptors [79] . Reduced protein kinase A same sample. Measuring only protein levels of SERCA2, activation impairs phosphorylation of phospholamban and the group working with Hasenfuss finds them to be consequently causes insufficient removal of the inhibitory decreased in heart failure [67] [68] [69] [70] and this has been action of unphosphorylated phospholamban. As a result, 21 confirmed in another study together with decreased mRNA the function of the SR Ca pump may become severely levels [40] . In contrast, seven other studies have not compromised. 21 detected changes in protein levels [1, 63, 64, [71] [72] [73] [74] , howFunctional activity of the SR Ca -ATPase in failing ever, only three of these provide parallel data on mRNA and nonfailing myocardium can be examined by measuring 21 and protein levels of both SERCA2 and phospholamban Ca uptake into SR vesicles and concomitant ATP [1, 63, 64] . The major finding is the protein levels remain consumption [80] or by studying systolic and diastolic 21 21 constant in cardiomyopathy despite of decreased mRNA [Ca ] levels in intact cells under various Ca loading i levels. As an explanation for this apparently conflicting conditions [15, 69] . In different animal models of heart 21 result, it is suggested that differential changes in synthesis failure, vesicular Ca -ATPase activity is invariably deand degradation of mRNA and proteins are associated with pressed. These models include rats with ischemic carheart failure [1, 63, 64, 75] , so that determination of mRNA diomyopathy [43, 81] , rabbits or dogs with tachycardialevels only is by no means representative of protein levels.
induced heart failure [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] 82] and guinea pigs with On the other hand, measurements of protein concentration heart failure induced by aortic banding [52] . Incidentally in may be subject to larger variability leading to less reliable the latter study, impaired function was also associated with 21 results than estimation of mRNA. This disparity may be a decrease in protein levels of SR Ca -ATPase and even more exaggerated by small sample sizes due to the phospholamban. 21 limited access to nonfailing control tissue. Furthermore, it Corresponding decreases in SR Ca uptake or SR 21 may not suffice to characterize heart muscles merely as Ca -ATPase activity are also observed in the failing failing or nonfailing, because Hasenfuss et al. [69] could human myocardium [63, 64, 67, 73, 74, 83] , however, other authors have not been able to show changes in pump The salient finding of prolonged relaxation time in the activity [84, 85] . Moreover, in the study of Schwinger et al. failing myocardium has been interpreted as impairment of 21 21 21 activities of SR Ca -ATPase as well as of Ca uptake Ca -handling proteins rather than changes in myofilament into the SR are decreased in the human myocardium function [18] . These authors had been ''surprised to find despite unchanged protein expression [63] .
that isometric tension development in muscles from the Isolated heart muscle from most mammalian species failing hearts was not depressed significantly compared responds to increasing frequency of stimulation with with the controls'' [18] . However, delayed relaxation (or 21 enhanced force development, but in failing myocardium delayed [Ca ] transients) can also be due to alterations at i from animals and human beings, the force-frequency the level of the myofilaments [100] or myofibrillar calcium response is blunted [16, 68, 69, [86] [87] [88] [89] [90] [91] . Hasenfuss et al. [69] sensitivity [101] . In analogy to the action of so-called 21 21 explain this blunted response by impaired SR Ca loading ''Ca sensitizers'' that enhance the sensitivity of contrac- 21 particularly with short stimulation intervals. In heart tile proteins for Ca binding but delay relaxation as a failure, shortening of the stimulation interval will unmask common side effect inherent in their mechanism of action 21 21 even subtle functional compromise of the SR Ca pump [102] , impaired dissociation of the Ca -myofilament 21 because time may become too short for sufficient Ca complexes could contribute to slow relaxation in heart 21 loading of the SR. In this group of muscles diastolic failure, although it should be noted that pure Ca function is impaired during high frequency stimulation, sensitizers are cardiotonic rather than cardiodepressive. 21 which is explained by insufficient Ca sequestration due Nevertheless, evidence for myofilament dysfunction in 21 to reduced SERCA2 levels. However, diastolic Ca heart failure is slowly emerging [6, 100, 103] . Besides concentration should only be elevated transiently, because functional deficiencies, simple loss of contractile elements 1 21 of other regulating processes, i.e., Na -Ca exchanger as anticipated from the recently recognized role of apop-
and, indirectly, also Na -K -ATPase. For long-lasting tosis in failure-induced remodeling may also contribute to 21 elevation of [Ca ] these additional regulators would also contractile dysfunction [104] [105] [106] .
i have to be affected by heart failure. Interestingly, in some Finally, in an attempt of rating the paper by Linck et al. 1 21 patients, cardiac expression of Na -Ca exchanger is [1] 3 years after its publication, we can state that this work upregulated during failure. Muscles from these hearts are -together with the paper by Schwinger et al. [63] found to be protected from diastolic dysfunction because published shortly before -have substantially contributed 21 cytosolic Ca not taken up by the SR is removed from the to our understanding of altered expression SERCA2 and cell due to enhanced exchanger activity [69] .
phospholamban in heart failure. The controversy on whether or not changes at the level of mRNA are paralleled by alterations in protein level and function has 7. Other subcellular alterations in hearts failure attracted much attention from the scientific community, but should not divert research interests away from other Heart failure is likely to induce multiple changes [92] possible cellular sites as targets for functional compromise. and the time has come to take a fresh look at various key players of excitation-contraction coupling including L- 21 type Ca channels, ryanodine receptors, mitochondria, References myofilaments. Recent evidence suggests that anyone of these structures may in fact be modified during heart[ 1] Linck B, Bohnık P, Eschenhagen T et al. Messenger RNA expresfailure despite the fact of earlier negative results sion and immunological quantification of phospholamban and SR- 21 
